Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer

Keyphrases

• Oropharyngeal Squamous Cell Carcinoma (OPSCC) 100%
• Induction Chemotherapy 100%
• Locoregionally Advanced 100%
• Concurrent Chemoradiotherapy 100%
• 5-fluorouracil (5-FU) 100%
• Radiotherapy 66%
• Chemoradiotherapy 66%
• Functional Outcome 66%
• Disease Control 66%
• Hydroxyurea 66%
• Concomitant Chemoradiation 66%
• Localized Disease 33%
• Head-and-neck 33%
• Treatment Strategy 33%
• Survivors 33%
• Clinical Outcomes 33%
• Disease Survival 33%
• Progression-free Survival 33%
• Cisplatin 33%
• 5-year Survival 33%
• Interferon-α (IFN-α) 33%
• Survival Rate 33%
• Treatment Toxicity 33%
• Induction Therapy 33%
• Initial Failure 33%
• Disease Groups 33%
• Disease Control Rate 33%
• Organ Preservation 33%
• Stage IV Disease 33%
• Conventional Treatment 33%
• Adjuvant Radiotherapy 33%
• Locoregional Control 33%
• Overall Survival Progression-free Survival 33%
• Distant Control 33%
• Residual Disease 33%
• Distant Disease 33%
• Clinical Complete Response 33%
• Radical Surgery 33%
• Leucovorin 33%
• Partial Glossectomy 33%
• Organ-sparing Surgery 33%
• Failure Pattern 33%
• Conservative Surgery 33%
• Radiotherapy Alone 33%
• Locoregional Recurrence 33%
• Radiotherapy Dose 33%
• Outcome Control 33%
• Functional Disease 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Chemoradiation Therapy 100%
• Oropharynx Cancer 100%
• Oropharynx Carcinoma 100%
• Disease 100%
• Fluorouracil 50%
• Hydroxycarbamide 33%
• Overall Survival 33%
• Progression Free Survival 33%
• Cisplatin 16%
• Recurrent Disease 16%
• Survival Rate 16%
• Interferon 16%
• Minimal Residual Disease 16%
• Folinic Acid 16%